Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.5 |
mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.5 |
mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |